Presentation TCT 2016

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Presenter: Stephen G. Ellis

October 31, 2016

REGISTER for free or LOG IN to view this content

Trial #1 - The Essentials of ... ABSORB III – Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Coronary

Presentation

TCT 2016

ACS/AMI

Up Next

Presentation TCT 2016

Left Main and MVD Stenting With Second Generation DES: The Florence Registry

Presenter: David Antoniucci (RETIRED)

October 31, 2016

More slides +

Presentation TCT 2016

ABSORB III Critique: Pros and Cons

Presenter: Ron Waksman

October 31, 2016

Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Salvatore Brugaletta

October 31, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.